Hepatitis C and nephropathy

Detalhes bibliográficos
Autor(a) principal: K. S. Vieira, Cinthia
Data de Publicação: 2022
Outros Autores: Lacerda, Mariane, V. Mussato, Alexandre, Gonçalves, Luiz Felipe
Tipo de documento: Artigo
Idioma: por
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/125380
Resumo: OBJECTIVE: Many studies have associated hepatitis C virus infection with extra-hepatic manifestations, including glomerulopathies. Our objective is to present a brief review of the literature regarding renal manifestations of hepatitis C and the summarized results from a study aimed at evaluating the association of asymptomatic urinary abnormalities in anti-HCV positive blood donors. MATERIALS AND METHODS: We carried out a cross- ectional, contemporary, controlled, open study from July 1997 to March 1998 at the Nephrology Services at Hospital de Clínicas de Porto Alegre in order to evaluate the prevalence of asymptomatic urinary abnormalities in hepatitis-C virus carriers. We included 58 blood donors positive for HCV and 128 donors negative for HCV (control group) without history of hepatic or renal disease and without other positive viral markers. We assessed prevalence of hematuria (> 5 red blood cells per high power field in urinary sediment); proteinuria (1 dipstick positive); microalbuminuria (microalbuminuria/creatinine ratio from an isolated sample >15.6 mg/g); and N-acetyl-beta-lucosaminidase (> 5.6 U/g creatinine). RESULTS: The data showed that the group positive for anti-HCV did not present significant urinary abnormalitiies when compared to a control group. The prevalence of hematuria and proteinuria in the HCV+ e HCV- groups was, respectively, 12.0% x 9.4% and 5.4% x 5.6% with no statistically significant differences. CONCLUSION: The prevalence of hematuria was similar to that found in the generalpopulation (3-20%).
id UFRGS-20_1a9e60754673112fe44e059e1bdc68b2
oai_identifier_str oai:seer.ufrgs.br:article/125380
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Hepatitis C and nephropathyHepatite C e nefropatiaHepatite Cnefropatiaalterações urinárias assintomáticasHepatitis Cnephropathyasymptomatic urinary abnormalitiesOBJECTIVE: Many studies have associated hepatitis C virus infection with extra-hepatic manifestations, including glomerulopathies. Our objective is to present a brief review of the literature regarding renal manifestations of hepatitis C and the summarized results from a study aimed at evaluating the association of asymptomatic urinary abnormalities in anti-HCV positive blood donors. MATERIALS AND METHODS: We carried out a cross- ectional, contemporary, controlled, open study from July 1997 to March 1998 at the Nephrology Services at Hospital de Clínicas de Porto Alegre in order to evaluate the prevalence of asymptomatic urinary abnormalities in hepatitis-C virus carriers. We included 58 blood donors positive for HCV and 128 donors negative for HCV (control group) without history of hepatic or renal disease and without other positive viral markers. We assessed prevalence of hematuria (> 5 red blood cells per high power field in urinary sediment); proteinuria (1 dipstick positive); microalbuminuria (microalbuminuria/creatinine ratio from an isolated sample >15.6 mg/g); and N-acetyl-beta-lucosaminidase (> 5.6 U/g creatinine). RESULTS: The data showed that the group positive for anti-HCV did not present significant urinary abnormalitiies when compared to a control group. The prevalence of hematuria and proteinuria in the HCV+ e HCV- groups was, respectively, 12.0% x 9.4% and 5.4% x 5.6% with no statistically significant differences. CONCLUSION: The prevalence of hematuria was similar to that found in the generalpopulation (3-20%).OBJETIVOS: Vários estudos associam a infecção crônica pelo vírus da hepatite C a manifestações extra-hepáticas, incluindo glomerulopatias. O objetivo deste artigo é fazer uma breve revisão da literatura sobre as manifestações renais da hepatite C e apresentar os resultados sumarizados de estudo que buscou avaliar a associação de alterações urinárias assintomáticas em doadores de sangue com anticorpos antiVHCHC positivo. MATERIAIS E MÉTODOS: Realizou-se um estudo transversal, contemporâneo, controlado e aberto no período de julho de 1997 a março de 1998 no Serviço de Nefrologia do HCPA para avaliar a prevalência de alterações urinárias assintomáticas em portadores do vírus da hepatite C. Foram incluídos no estudo os 58 doadores de sangue VHC+ e 128 doadores VHC- (grupo controle) que não apresentavam história de doença hepática ou renal ou outros marcadores virais positivos. Avaliou-se a prevalência de hematúria (> 5 hemácias/campo de grande aumento no E.Q.U), proteinúria [uma (+) no exame por fita do E.Q.U], microalbuminúria (índice microalbuminúria/creatininúria em amostra isolada > 15,6 mg/g), N-acetil-beta-D-glucosaminidase (> 5,6U/g creatinina).  RESULTADOS: Não foi constatada anormalidade urinária significativa no grupo VHC+, comparativamente com o grupo controle. A prevalência de hematúria e proteinúria nos grupos VHC+ e VHC- foi respectivamente 12,0% x 9,4% e 5,4% x 5,5% , sem diferença estatística entre os 2 grupos. CONCLUSÃO: A prevalência de hematúria foi semelhante à da população geral, que oscila entre 3-20%.HCPA/FAMED/UFRGS2022-06-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/125380Clinical & Biomedical Research; Vol. 20 No. 3 (2000): Revista HCPAClinical and Biomedical Research; v. 20 n. 3 (2000): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/125380/85233http://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessK. S. Vieira, Cinthia Lacerda, Mariane V. Mussato, Alexandre Gonçalves, Luiz Felipe 2022-09-16T16:33:15Zoai:seer.ufrgs.br:article/125380Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2022-09-16T16:33:15Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Hepatitis C and nephropathy
Hepatite C e nefropatia
title Hepatitis C and nephropathy
spellingShingle Hepatitis C and nephropathy
K. S. Vieira, Cinthia
Hepatite C
nefropatia
alterações urinárias assintomáticas
Hepatitis C
nephropathy
asymptomatic urinary abnormalities
title_short Hepatitis C and nephropathy
title_full Hepatitis C and nephropathy
title_fullStr Hepatitis C and nephropathy
title_full_unstemmed Hepatitis C and nephropathy
title_sort Hepatitis C and nephropathy
author K. S. Vieira, Cinthia
author_facet K. S. Vieira, Cinthia
Lacerda, Mariane
V. Mussato, Alexandre
Gonçalves, Luiz Felipe
author_role author
author2 Lacerda, Mariane
V. Mussato, Alexandre
Gonçalves, Luiz Felipe
author2_role author
author
author
dc.contributor.author.fl_str_mv K. S. Vieira, Cinthia
Lacerda, Mariane
V. Mussato, Alexandre
Gonçalves, Luiz Felipe
dc.subject.por.fl_str_mv Hepatite C
nefropatia
alterações urinárias assintomáticas
Hepatitis C
nephropathy
asymptomatic urinary abnormalities
topic Hepatite C
nefropatia
alterações urinárias assintomáticas
Hepatitis C
nephropathy
asymptomatic urinary abnormalities
description OBJECTIVE: Many studies have associated hepatitis C virus infection with extra-hepatic manifestations, including glomerulopathies. Our objective is to present a brief review of the literature regarding renal manifestations of hepatitis C and the summarized results from a study aimed at evaluating the association of asymptomatic urinary abnormalities in anti-HCV positive blood donors. MATERIALS AND METHODS: We carried out a cross- ectional, contemporary, controlled, open study from July 1997 to March 1998 at the Nephrology Services at Hospital de Clínicas de Porto Alegre in order to evaluate the prevalence of asymptomatic urinary abnormalities in hepatitis-C virus carriers. We included 58 blood donors positive for HCV and 128 donors negative for HCV (control group) without history of hepatic or renal disease and without other positive viral markers. We assessed prevalence of hematuria (> 5 red blood cells per high power field in urinary sediment); proteinuria (1 dipstick positive); microalbuminuria (microalbuminuria/creatinine ratio from an isolated sample >15.6 mg/g); and N-acetyl-beta-lucosaminidase (> 5.6 U/g creatinine). RESULTS: The data showed that the group positive for anti-HCV did not present significant urinary abnormalitiies when compared to a control group. The prevalence of hematuria and proteinuria in the HCV+ e HCV- groups was, respectively, 12.0% x 9.4% and 5.4% x 5.6% with no statistically significant differences. CONCLUSION: The prevalence of hematuria was similar to that found in the generalpopulation (3-20%).
publishDate 2022
dc.date.none.fl_str_mv 2022-06-23
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliado por Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/125380
url https://seer.ufrgs.br/index.php/hcpa/article/view/125380
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/125380/85233
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 20 No. 3 (2000): Revista HCPA
Clinical and Biomedical Research; v. 20 n. 3 (2000): Revista HCPA
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767056967532544